Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

AdvaMed Praises CMS Draft Rule Improving Access to Alzheimer’s, Cancer Diagnostics

  • Post author:PacConAdmin
  • Post published:July 15, 2024
  • Post category:Uncategorized

AdvaMed commended CMS for its July 10 proposed rule that includes separate payments for diagnostic radiopharmaceuticals are used to diagnose and treat diseases such as Alzheimer’s and cancer. Source: Drug…

Continue ReadingAdvaMed Praises CMS Draft Rule Improving Access to Alzheimer’s, Cancer Diagnostics

Texas Compounder Sentenced to 2+ Years for Illegal Kickbacks, Money Laundering

  • Post author:PacConAdmin
  • Post published:July 15, 2024
  • Post category:Uncategorized

A Texas pharmaceutical marketer was sentenced to two years and five months in federal prison and ordered to pay over $59 million in restitution for conspiring to defraud the US,…

Continue ReadingTexas Compounder Sentenced to 2+ Years for Illegal Kickbacks, Money Laundering

Regulatory Update — Week of July 8, 2024

  • Post author:PacConAdmin
  • Post published:July 12, 2024
  • Post category:Uncategorized

This week, the FDA published a final guidance on clinical considerations for studies of opioid use devices. Draft guidances were issued for misinformation about drugs and devices, use-related risk analyses…

Continue ReadingRegulatory Update — Week of July 8, 2024

New Class I Hamilton Ventilator Recall, Updated Class I Recalls for Philips, Megadyne

  • Post author:PacConAdmin
  • Post published:July 12, 2024
  • Post category:Uncategorized

Hamilton Medical has issued a recall for correction of the software in one of its ventilators, an issue that could cause the device to fail during procedures, a recall which…

Continue ReadingNew Class I Hamilton Ventilator Recall, Updated Class I Recalls for Philips, Megadyne

FDA Raises the Bar on 510(k)s for Dental Resin Devices, Ultraviolet Curing Lights

  • Post author:PacConAdmin
  • Post published:July 12, 2024
  • Post category:Uncategorized

The FDA offers new recommendations for testing and information to include in 510(k) submissions for dental resin devices and the ultraviolet curing lights used to set the resins, in two…

Continue ReadingFDA Raises the Bar on 510(k)s for Dental Resin Devices, Ultraviolet Curing Lights

Novo Nordisk Gets FDA CRL for Once-Weekly Insulin BLA

  • Post author:PacConAdmin
  • Post published:July 12, 2024
  • Post category:Uncategorized

The FDA issued a complete response letter (CRL) to Novo Nordisk for insulin icodec — a once-weekly long-acting human insulin analogue — raising questions about the manufacturing process and the…

Continue ReadingNovo Nordisk Gets FDA CRL for Once-Weekly Insulin BLA

FDA Issues Final Guidance on Pivotal Trials for Opioid Use Disorder Devices

  • Post author:PacConAdmin
  • Post published:July 11, 2024
  • Post category:Uncategorized

The FDA has finalized its guidance on crafting phase 3 clinical trials for devices designed to treat opioid use disorder (OUD), providing sponsors with direction on defining patient populations, recording…

Continue ReadingFDA Issues Final Guidance on Pivotal Trials for Opioid Use Disorder Devices

“Do Not Use” Certain Medtronic EMG Endotracheal Tubes, FDA Warns

  • Post author:PacConAdmin
  • Post published:July 11, 2024
  • Post category:Uncategorized

Health care providers and facilities are being warned by the FDA to stop using Medtronic NIM (neural integrity monitor) Contact EMG (electromyogram) reinforced endotracheal tubes and NIM Standard EMG reinforced…

Continue Reading“Do Not Use” Certain Medtronic EMG Endotracheal Tubes, FDA Warns

Guest Column: Effects of the Chevron Decision on the FDA’s Scientific Conclusions

  • Post author:PacConAdmin
  • Post published:July 11, 2024
  • Post category:Uncategorized

Lost in the politics-oriented follow up to the presidential debate between Joe Biden and Donald Trump was the substance of what they both said during the debate about the actual…

Continue ReadingGuest Column: Effects of the Chevron Decision on the FDA’s Scientific Conclusions

FTC Supports Proposed Rule That Would Cut Down on Patent System Abuse

  • Post author:PacConAdmin
  • Post published:July 11, 2024
  • Post category:Uncategorized

The FTC submitted a comment supporting a proposed US Patent and Trademark Office (USPTO) rule to address patent system abuse such as the creation of overlapping patent rights known as…

Continue ReadingFTC Supports Proposed Rule That Would Cut Down on Patent System Abuse
  • Go to the previous page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 143
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company